These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6248148)

  • 1. [Changes in the serum acid phosphatase activity of guinea pigs poisoned with C1 perfringens type A toxin and a mixture of toxin and a broth culture filtrate].
    Tselukh AV; Levitskiĭ AP; Shtefan EE
    Biull Eksp Biol Med; 1980 Apr; 89(4):426-8. PubMed ID: 6248148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the electrical activity of the cerebral cortex under the combined influence of Cl. perfringens type A toxin and products of Cl. butyricum activity].
    Tselukh AV; Makul'kon RF; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1976; 82(11):1305-10. PubMed ID: 189855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microcirculatory changes following the combined action of the toxin of C1. perfringens type A and biological products of C1. butyricum].
    Tselukh AV; Donskikh EA; Shtefan EE; Shtykhno IuM
    Biull Eksp Biol Med; 1977 Nov; 84(11):552-4. PubMed ID: 201314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of aminazin on changes in the electrical activity of the cerebral cortex under the influence of the toxin C1. perfringens type A].
    Tselukh AV; Makul'kin RF; Shandra AA
    Biull Eksp Biol Med; 1977 Oct; 84(10):412-6. PubMed ID: 199290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of toxins of Clostridium perfringens type A in infected animals by using the ELISA test].
    Nowakowska M; Bartoszcze M; Matras J
    Med Dosw Mikrobiol; 1989; 41(3-4):166-9. PubMed ID: 2561810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of Clostridium difficile and Clostridium perfringens iota toxins in experimental lincomycin-associated colitis of rabbits.
    Rehg JE; Pakes SP
    Lab Anim Sci; 1982 Jun; 32(3):253-7. PubMed ID: 6285077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the electric activity of the cerebral cortex in poisoning caused by Cl. perfringens toxin type A].
    Tselukh AV; Makul'kin RF; Kryzhanovskaia GN
    Biull Eksp Biol Med; 1976 Oct; 82(10):1192-8. PubMed ID: 196701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [alpha-toxin (phospholipase C) of Clostridium perfringens (author's transl)].
    Ohsaka A
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():121-44. PubMed ID: 194279
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neonatal diarrhoea in pigs: alpha- and beta2-toxin produced by Clostridium perfringens].
    Hendriksen SW; van Leengoed LA; Roest HI; van Nes A
    Tijdschr Diergeneeskd; 2006 Dec; 131(24):910-3. PubMed ID: 17278609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of alpha-toxin of Clostridium perfringens and its role in the pathogenesis of gas gangrene (author's transl)].
    Murata R; Ohsaka A
    Nihon Saikingaku Zasshi; 1977 Sep; 32(5):671-89. PubMed ID: 199761
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of the protective immunogenicity of native and recombinant Clostridium haemolyticum phospholipase C (beta toxin) in guinea pigs.
    Hauer PJ; Yeary TJ; Rosenbusch RF
    Vaccine; 2006 Jan; 24(2):124-32. PubMed ID: 16140435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Properties and hemolytic action of Clostridium perfringens theta-toxin (author's transl)].
    Hase J; Mitsui K
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():145-59. PubMed ID: 194280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacteriologic diagnosis of Clostridium perfringens infection].
    Sebald M
    Rev Prat; 1990 Mar; 40(7):689-90. PubMed ID: 2183343
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridium perfringens iota toxin: synergism between two proteins.
    Stiles BG; Wilkins TD
    Toxicon; 1986; 24(8):767-73. PubMed ID: 2877514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the demonstration of Clostridium (C1.) welchii toxin with the intracutaneous test in immunized guinea pigs].
    Hartwigk H; Franke F
    Berl Munch Tierarztl Wochenschr; 1968 Mar; 81(6):111-2. PubMed ID: 4301032
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical localization of Clostridium perfringens beta2-toxin in the gastrointestinal tract of horses.
    Bacciarini LN; Boerlin P; Straub R; Frey J; Gröne A
    Vet Pathol; 2003 Jul; 40(4):376-81. PubMed ID: 12824509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.